On the other hand, it acts as tumor suppressor miRNA in metastatic cancer and in an advanced clinical stage of hepatocellular carcinoma by targeting ARHGAP18, Rabl3 and snail which are up-regulated and implicated in migration and metastasis of this type of cancer cells (51, 52, 56). This evidence concerns the gene ARHGAP18 and cancer.